John Albert, MD
Rheumatology · Glendale, WINPI 1861428070
Payments from drug & device makers
Across 1,295 payments — averaging $285.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$317K
- Sobi, Inc$35K
- Boehringer Ingelheim$6K
- AstraZeneca$2K
- AbbVie$1K
- ANI Pharmaceuticals, Inc.$1K
- plus $6K from 31 others
Across 1 payment — averaging $309.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$309
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 638 | $316,961 |
| Sobi, Inc | 56 | $35,463 |
| Boehringer Ingelheim | 17 | $6,131 |
| AstraZeneca(2 entities) | 52 | $1,830 |
| AbbVie | 101 | $1,291 |
| ANI Pharmaceuticals, Inc. | 40 | $1,150 |
| UCB, Inc. | 63 | $1,021 |
| Novartis | 56 | $1,002 |
| Pfizer | 77 | $795 |
| Johnson & Johnson | 36 | $723 |
| Lilly USA, LLC | 31 | $528 |
| GSK | 38 | $463 |
| Mallinckrodt Hospital Products Inc. | 10 | $296 |
| E.r. Squibb & Sons, L.L.C. | 11 | $204 |
| Genentech USA, Inc. | 9 | $191 |
| Organon | 7 | $149 |
| Sanofi | 8 | $148 |
| Sandoz | 6 | $118 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $91 |
| Radius Health, Inc. | 4 | $85 |
| Ultragenyx Pharmaceutical Inc. | 4 | $85 |
| Celltrion USA Inc. | 2 | $69 |
| Ferring Pharmaceuticals Inc. | 3 | $66 |
| Aurinia Pharma U.S., Inc. | 4 | $65 |
| Fresenius Kabi USA, LLC | 3 | $64 |
| Hospira, Inc. | 3 | $60 |
| Collegium Pharmaceutical, Inc. | 3 | $44 |
| Pacira Therapeutics, Inc. | 1 | $28 |
| United Therapeutics Corporation | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $15 |
| Merck | 1 | $15 |
| Kyowa Kirin, Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Bioventus LLC | 1 | $11 |
How this compares
$369,274 in reported general payments places this provider in the 95th percentile of 120 rheumatology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Glendale
- Kurt OelkeGlendale$1.8M
- Arnold LimGlendale$8K
- Jonathan KushiGlendale$5K
- Katherine FinnGlendale$2K
- Farrukh PashaGlendale$1K
- Steven BergquistGlendale$722
- Juliana ShahGlendale$513
- Daniel MaloneBeaver Dam$505K
- Ekaterina SoforoSheboygan$464K
- Fardina MalikMadison$446K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.